dcterms.isReferencedBy |
Rizzetto, M., Hepatitis B vaccination: Current status (1991) Minerva Gastroenterol Dietol, 45, pp. 199-205; Annual meeting of the Safe Injection Global Network (SIGN) (2010) Injection Safety in Light of Primary Health Care Reforms, , World Health Organization (WHO) WHO. Geneva, Switzerland, V 4.1, EB126/15; Ayoola, E.A., Gadour, M.O., Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection (2004) J Gastrenetrol Hepatol, 19, pp. 665-669; Hoofnagle, J.H., Reactivation of hepatitis B (2009) Hepatology, 49, pp. S156-S165; EASL-EORTC clinical practice guidelines: "management of hepatocellular carcinoma" (2012) J Hepatol, 56, pp. 908-943; Shaaban, F.A., Hassanin, A.I., Samy, S.M., Salama, S.I., Said, Z.N., Long-term immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt (2007) East Mediterr Health J, 13, pp. 750-757; Zakaria, S., Fouad, R., Shaker, O., Changing patterns of acute viral hepatitis at a major urban referral center in Egypt (2007) Clin Infect Dis, 44, pp. e30-e36; Frank, C., Mohamed, M.K., Strickland, G.T., The role of parenteral antischistosomal therapy in the spread of HCV in Egypt (2000) Lancet, 355, pp. 887-891; Liu, C.J., Chen, D.S., Chen, P.J., Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT (2006) J Clin Virol, 36, pp. S33-S44; Fattovich, G., Tagger, A., Brollo, L., Hepatitis C virus in fection in chronic hepatitis B virus carriers (1991) J Infect Dis, 163, pp. 400-402; Crespo, J., Lozano, J.L., De La Cruz, F., Prevalence and significance of hepatitis C viremia in chronic active hepatitis B (1994) Am J Gastroeneterol, 89, pp. 1147-1151; Samal, J., Kandpal, M., Vivekanandan, P., Molecular mechanisms underlying occult hepatitis B virus infection (2012) Clin Microbiol Rev, 25 (1), p. 142; Chisari, F.V., Klopchin, K., Moriyama, T., Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice (1989) Cell, 59, pp. 1145-1156; Besisik, F., Karaca, C., Aky�z, F., Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection (2003) J Hepatol, 38, pp. 506-510; Beck, J., Nassal, M., Hepatitis B virus replication (2007) World J Gastroenterol, 13 (1), pp. 48-64; Bouchard, M.J., Schneider, R.J., The enigmatic X gene of hepatitis B virus (2004) J Virol, 78 (23), pp. 12725-12734; Carman, W.F., Zanetti, A.R., Karayiannis, P., Vaccine-induced escape mutant of hepatitis B virus (1990) Lancet, 336, pp. 325-329; El-Zayadi, A.R., Ibrahim, E.H., Badran, H.M., Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission (2008) Transfus Med, 18, pp. 55-61; Raimondo, G., Allain, J.P., Brunetto, M.R., Statements from the Taormina expert meeting on occult hepatitis B virus infection (2008) J Hepatol, 49, pp. 652-657; Chaudhuri, V., Tayal, R., Nayak, B., Acharya, S.K., Panda, S.K., Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter (2004) Gastroenterology, 127, pp. 1356-1371; Saito, T., Shinzawa, H., Uchida, T., Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B (1999) J Med Virol, 58, pp. 325-331; Berasain, C., Bet�s, M., Panizo, A., Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology (2000) Gut, 47, pp. 429-435; Honarkar, Z., Alavian, S.M., Samiee, S., Saeedfar, K., Zali, M.R., Occult hepatitis B among chronic liver disease patients (2005) Saudi Med J, 26, pp. 601-606; Kazemi-Shirazi, L., Petermann, D., Muller, C., Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C (2000) J Hepatol, 33 (5), pp. 785-790; Cuchacovich, R., Japa, S., Huang, W.Q., Detection of bacterial DNA in Latin American patients with reactive arthritis by polymerase chain reaction and sequencing analysis (2002) J Rheumatol, 29, pp. 1426-1429; Allain, J.P., Occult hepatitis B virus infection (2005) Hepatitis B Ann, 2, pp. 14-30; De Mitri, M.S., Cassini, R., Bernardi, M., Hepatitis B virus-related hepatocarcinogenesis: Molecular oncogenic potential of clear or occult infections (2010) Eur J Cancer, 46, pp. 2178-2186; Hou, J., Wang, Z., Cheng, J., Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers (2001) Hepatology, 34 (5), pp. 1027-1034; Jang, J.Y., Jeong, S.W., Cheon, S.R., Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients (2011) Korean J Hepatol, 17, pp. 206-212; Lok, A., Chronic hepatitis B (2002) N Engl J Med, 346 (22), pp. 1682-1683; Georgiadou, S.P., Zachou, K., Rigopoulou, E., Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases (2004) J Viral Hepatol, 11, pp. 358-365; Matsuoka, S., Nirei, K., Tamura, A., Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C (2008) Intervirology, 51, pp. 352-361; Selim, H.S., Abou-Donia, H.A., Taha, H.A., El Azab, G.I., Bakry, A.F., Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes (2011) Eur J Intern Med, 22, pp. 187-190; Fang, Y., Shang, Q.L., Liu, J.Y., Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China (2009) J Infect, 58 (5), pp. 383-388; Giannini, E., Ceppa, P., Botta, F., Fasoli, A., Romagnoli, P., Ansaldi, F., Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients (2003) Liver Int, 23, pp. 12-18; Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C (2002) J Clin Microbiol, 40, pp. 4068-4071; Roman, S., Tanaka, Y., Khan, A., Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population (2010) J Med Virol, 82 (9), pp. 1527-1536; De Matos, M.A., Ferreira, R.C., Rodrigues, F.P., Occult hepatitis B virus infection among injecting drug users in the Central-West region of Brazil (2013) Mem Inst Oswaldo Cruz, 108 (3), pp. 386-389; Rossi, D., Sala, L., Minisini, R., Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia (2009) Leuk Lymphoma, 50 (4), pp. 604-611; MacDonald, T., Pediatric cancer: A comprehensive review. Part I: Biology, epidemiology, common tumours, principles of treatment and late effects (2010) Can Pharm J, 143 (4), pp. 176-183; Shi, J., Zhu, L., Liu, S., Xie, W.F., A meta-analysis of case control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China (2005) Brit J Cancer, 92, pp. 607-612; Cheng, A.L., Hsiung, C.A., Su, I.J., Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma (2003) Hepatology, 37, pp. 1320-1328; Banerjee, A., Chandra, P.K., Datta, S., Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India (2007) J Clin Virol, 40, pp. 312-317; Brojer, E., Grabarczyk, P., Liszewski, G., Mikulska, M., Allain, J.P., Letowska, M., Characterization of HBV DNA+/HbsAg- blood donors in Poland identified by triplex NAT (2006) Hepatology, 44, pp. 1666-1674; Pollicino, T., Belloni, L., Raffa, G., Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones (2006) Gastroenterology, 130, pp. 823-837; Sheldon, J., Rodes, B., Zoulim, F., Bartholomeusz, A., Soriano, V., Mutations affecting the replication capacity of the hepatitis B virus (2006) J Viral Hepat, 13, pp. 427-434; La'Ulu, S.L., Roberts, W.L., The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays (2006) Am J Clin Pathol, 125, pp. 748-751; Katsoulidou, A., Paraskevis, D., Magiorkinis, E., Molecular characterization of occult hepatitis B cases in Greek blood donors (2009) J Med Virol, 81 (5), pp. 815-825; Van Hemert, F.J., Zaaijer, H.L., Berkhout, B., Lukashov, V.V., Occult hepatitis B infection: An evolutionary scenario (2008) Virol J, 5 (146), p. 146; Fang, Y., Teng, X., Xu, W.Z., Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C (2009) J Med Virol, 81 (5), pp. 826-835; Fang, Z.L., Zhuang, H., Wang, X.Y., Ge, X.M., Harrison, T.J., Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China (2004) World J Gastroenterol, 10 (22), pp. 3264-3268; Datta, S., Banerjee, A., Chandra, P.K., Chowdhury, A., Chakravarty, R., Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers (2006) J Med Virol, 78 (1), pp. 53-59; Kumar, G.T., Kazim, S.N., Kumar, M., Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection (2009) J Gastroenterol Hepatol, 24 (4), pp. 588-598; Candotti, D., Grabarczyk, P., Ghiazza, P., Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains (2008) J Hepatol, 49 (4), pp. 537-547; Hassan, Z.K., Hafez, M.M., Mansor, T.M., Zekri, A.N., Occult HBV infection among Egyptian hepatocellular carcinoma patients (2011) Virol J, 8 (1), p. 90; Arababadi, M.K., Pourfathollah, A.A., Jafarzadeh, A., Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection (2011) Hepatol Gastroenterol, 35, pp. 554-559; Allain, J.P., Occult hepatitis B virus infection (2004) Transfus Clin Biol, 11, pp. 18-25; Torbenson, M., Thomas, D.L., Occult hepatitis B (2002) Lancet Infect Dis, 2, pp. 479-486; Silva, C.M., Costi, C., Costa, C., Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil (2005) J Infect, 51, pp. 24-29; Allain, J.P., Cox, L., Challenges in hepatitis B detection among blood donors (2011) Curr Opin Hematol, 18, pp. 46-466 |
|